R Pavanni
Overview
Explore the profile of R Pavanni including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
367
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kumar P, Paing S, Li H, Pavanni R, Yuen Y, Zhao Y, et al.
Sci Rep
. 2015 Nov;
5:15492.
PMID: 26522888
We examined if caffeine intake has a differential effect in subjects with high and low genetic susceptibility to Parkinson's disease (PD), a common neurodegenerative disorder. A case control study involving...
2.
Peeraully T, Hameed S, Cheong P, Pavanni R, Hussein K, Fook-Chong S, et al.
Int J Clin Pract
. 2013 Jul;
67(8):801-6.
PMID: 23869681
Objectives: We determined the prevalence, range and factors influencing the use of complementary therapy among hemifacial spasm patients and compared the patterns of use of complementary therapies across different movement...
3.
Tan E, Kwok H, Kwok H, Tan L, Zhao W, Prakash K, et al.
Neurology
. 2010 Aug;
75(6):508-12.
PMID: 20697102
Objective: A genome-wide association study (GWAS) in the Japanese population identified 2 new Parkinson disease (PD) susceptibility loci on 1q32 (PARK16) (OMIM 613164) and BST1. We analyzed single nucleotide polymorphism...
4.
Tan E, Tan L, Lim H, Li R, Tang M, Yih Y, et al.
Hum Genet
. 2008 Sep;
124(3):287-8.
PMID: 18781329
We showed that the frequency of a LRRK2 variant (c.4883G > C, R1628P) was higher in Parkinson's disease (PD) compared to controls (8.4 vs. 3.4%, P = 0.046, OR 2.5,...
5.
Tan E, Prakash K, Fook-Chong S, Yih Y, Chua E, Lum S, et al.
Neurology
. 2007 Mar;
68(10):790-1.
PMID: 17339592
No abstract available.
6.
The LRRK2 Gly2385Arg variant is associated with Parkinson's disease: genetic and functional evidence
Tan E, Zhao Y, Skipper L, Tan M, Di Fonzo A, Sun L, et al.
Hum Genet
. 2006 Oct;
120(6):857-63.
PMID: 17019612
Evidence of LRRK2 haplotypes associated with Parkinson's disease (PD) risk was recently found in the Chinese population from Singapore, and a common LRRK2 missense variant, Gly2385Arg, was independently detected as...
7.
Lim S, Zhao Y, Chua E, Law H, Yuen Y, Pavanni R, et al.
Neurosci Lett
. 2006 May;
403(1-2):11-4.
PMID: 16687213
Recent reports of SCA2 and SCA3 patients who presented with levodopa responsive parkinsonism have generated considerable interest as they have implications for genetic testing. It is unclear whether ethnic race...
8.
Skipper L, Shen H, Chua E, Bonnard C, Kolatkar P, Tan L, et al.
Neurology
. 2005 Oct;
65(8):1319-21.
PMID: 16247070
A comprehensive sequence analysis of 29 exons that code for the functional domains of LRRK2 in 160 nondominant Parkinson disease (PD) patients was performed. Novel variant screening in a further...
9.
Tan E, Puong K, Chan D, Yew K, Fook-Chong S, Shen H, et al.
Hum Genet
. 2005 Oct;
118(3-4):484-8.
PMID: 16244875
We provided data to show that the transcriptional activity of wildtype -258T in the parkin promoter region was significantly higher than the -258G variant in human cell lines. The transcriptional...
10.
Tan E, Yew K, Chua E, Shen H, Jamora R, Lee E, et al.
Clin Genet
. 2005 Oct;
68(5):468-70.
PMID: 16207217
No abstract available.